The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

    Review: Effect of lycopene on prostate cancer progression

    Researchers from the Queen’s University Belfast, in Northern Ireland reviewed the association between lycopene and the progression of prostate cancer.

    First, the details.

    • 8 studies were identified (5 failed to include a comparative control group).

    And, the results.

    • 6 studies reported that higher intake of lycopene intake was associated with lower PSA blood levels.
      • PSA (prostate-specific antigen) is a protein in men’s blood that’s used to screen for and monitor the progress of prostate cancer.
    • In 1 study, rates of cancer progression measured by bone scan were lower in those taking lycopene.
    • Lycopene was associated with lower cancer-related symptoms (pain, urinary tract symptoms), and was well tolerated.

    The bottom line?

    Despite these positive results, the authors concluded, the evidence available to date is insufficient to draw a firm conclusion with respect to lycopene supplementation in prostate cancer patients.”

    They recommended more and larger studies.

    1/12/10 19:30 JR

    Leave a Comment

    You must be logged in to post a comment.